CaribPR Wire

CaribPR Wire, NEW YORK, NY, Fri. Feb. 12, 2021: Get ready for the one-stop Green Glove Bespoke Service for Barbados’ cannabis sector.

Invest Caribbean, the global private sector investment agency of the Caribbean, has partnered with the international project services Bespoke Division of the Barbados-based company, The Ritzury Group, to launch the service for investors seeking to invest in the country’s new medical marijuana sector, which opened officially for business in January.

According to ICN’s CEO, Felicia J. Persaud, and The Ritzury Group’s Executive Chairman, Danielle Corbin, the Green Glove Bespoke Service offerings will include all ground-up project development services relating to Barbados’ new cannabis sector. These will include policy research, feasibility studies, competitive analysis reports, licensing applications, globally accepted business plan services, matching foreign investors with local entrepreneurs, scouting and procurement of project locations, company registration, legal and operations management services, capital raise and branding and marketing services – all under one roof.

“Teaming with the Ritzury Group will allow ICN to expand its current service offerings in the cannabis sector, into growing the medical marijuana sector in Barbados,” said Persaud. “This is intended to help investors who are anxious to invest in this market but are confused about where to begin or how to collaborate with local entrepreneurs. Our Green Glove service is intended to take the hassle out of the process and provide one-stop shopping at its best.”

“This is a new and exciting industry for Barbados,” said Corbin. “We have seen an exponential increase of interest and activity in this sector, especially in recent months, and this powerful partnership will help aid in making this sector internationally lauded, while providing ease of doing business in this sector here for the savvy investor.”

Ritzury and ICN, which recently completed a historic global Caribbean inauguration celebration of the US’ first Black Caribbean American Vice President, Kamala Harris, featuring a number of Barbados entertainers, will also simultaneously focus on offering the same services to investors and governments in the health care, manufacturing, real estate and energy sectors.

The companies are also currently ready to work with middle to large operating ‘distressed’ companies that are seeking growth capital – debt and/ or equity or some form of liquidity, whether through partial sale, recapitalization or via a management buy-in (MBI) or a management buyout (MBO).

For more information contact ICN and Ritzury at investcaribbeannow.com or theritzurygroup.com

ABOUT ICN

Invest Caribbean was founded in 2011 by Caribbean-born immigrant, Felicia J. Persaud, and is the global private sector investment agency of the Caribbean. ICN provides specialized, fundraising support for project developers and governments, and works alongside private equity and debt funders to add depth, breadth and responsiveness to clients fundraising and investor relations efforts in the real estate, cannabis, health care, energy, mining and manufacturing sectors. The company, through CaribPR Wire and Hard Beat Communications, also offers global content distribution including SEC filings and IR webcasting and teleconferencing as well as customized digital experiences and creatives. For more information see investcaribbeannow.com

ABOUT THE RITZURY GROUP

The Ritzury Group – Bespoke Division is a Barbados-based international project services division with a focus on project design and development, project operations management and investor – client relations. The Bespoke Division works hand in hand with project shareholders globally to produce high revenue, sustainable projects. The Group has evaluated, as of December 2020, over USD 9.3 billion in global Client Projects. For more information see theritzurygroup.com

###

TORONTO, Dec. 5, 2019 /CNW/ – Ample Organics Inc. and the Medicinal Cannabis Authority (”MCA”) in Saint Vincent and the Grenadines, together, are proud to announce their partnership to strengthen the medicinal cannabis industry in Saint Vincent and the Grenadines by activating AmpleCentral™ — the world’s first national Cannabis Tracking System built for regulators.

Leveraging its extensive cannabis industry domain expertise at the federally regulated level, Ample Organics will be providing sound industry-wide advice to the MCA as the medicinal cannabis industry emerges in St. Vincent and the Grenadines. Together, a two-phase approach will be established to facilitate the rapid rollout of the new medicinal cannabis program. Initially, the Ample Organics seed-to-sale software platform will be deployed to empower the MCA, along with physicians and pharmacists, to register and service medicinal cannabis patients. This software platform is the trusted solution serving the world’s largest cannabis companies and over 70% of Canadian License Holders. Concurrently, Ample Organics will be working closely with the MCA and stakeholders to customize and deploy AmpleCentral™ specifically for St. Vincent and the Grenadines. A first-of-its-kind jurisdictional track-and-trace database, AmpleCentral™ is designed for governments to facilitate sophisticated reporting and to assist regulators with ensuring compliance, verifying product quantity and quality, taxation, and preventing diversion and inversion. This technology connects data points across the national cannabis supply chain, providing regulators with the information necessary to assure public, product, and patient safety.

“We believe that this is a hugely important milestone,” says John Prentice, President and CEO of Ample Organics. “It will be the very first implementation of a true national tracking system within the cannabis industry anywhere in the world, and it has allowed us the opportunity to engage with government agencies across the globe as new markets arise. With the support of the Government of Canada, we are building AmpleCentral™ to empower other federal governments to regulate, monitor, and monetize their cannabis industries effectively. This public-private partnership enables the MCA to leverage our unique and extensive expertise operating compliance systems on a national scale. St. Vincent and the Grenadines’ well-thought-out and comprehensive regulatory framework, should, and will, serve as a model for the CARICOM nations and any other national jurisdiction considering a forward-thinking cannabis program.”

“We are establishing this industry with the mantra that a ‘Medicinal Cannabis Industry begins with Science and Technology,’” says Dr. Jerrol Thompson, CEO of the Medicinal Cannabis Authority. “That is why we are taking this bold lead to invest, and an early stage, in a Central Inventory Management Traceability system that will: (1) eliminate diversion; (2) facilitate real-time supply chain reporting; (3) support our banking solution and compliance regime; (4) and provide a safety net for product recall.”

Over the past few months, as part of a government mandate, the MCA has rolled out an innovative country-wide education program providing theoretical and practical training to indoor and outdoor cultivators, including industry best-practices and Good Agricultural and Collection Practices (GACP). Ample Organics is dedicated to sharing the responsibility to foster an educated and informed cannabis industry, and therefore, will provide AmpleLearn™ as a way to administer education programs to enhance the training and education available.

“One of the reasons we have chosen to work with the Medicinal Cannabis Authority in St. Vincent and the Grenadines is their commitment to ensuring a successful cannabis industry through education,” says Tom Ritchie, VP of Accounts & Education at Ample Organics. “It is vital to us that traditional cultivators have proper educational tools available to them so that they, too, can thrive in a regulated cannabis industry. As the first in the world to develop a certification program for seed-to-sale software operators, we have the know-how to help administer education and training programs by leveraging AmpleLearn™, our online Learning Management System. We are committed to supporting the initiatives that the MCA is launching and look forward to the future.”

About Ample Organics:
Founded in 2014, Ample Organics is adopted by more Canadian Licensed Holders than any other cannabis software solution. A complete ecosystem for cannabis businesses, the technology platform makes compliance easy by tracking individual plants from seed to consumer and reporting every detail of the growth, production, and sales processes. Our team of cannabis industry and technology experts designed the platform to facilitate compliance and transparency, while enhancing overall business efficiency and operational intelligence. The software continues to be the most trusted solution for cannabis producers, manufacturers, distributors, physicians, clinics, laboratories, retailers, and educators.
Visit AmpleOrganics.com.

About the Medicinal Cannabis Authority:
The Medicinal Cannabis Authority was established through the Medicinal Cannabis Industry Act, 2018. It is a body corporate with a mandate to regulate the cultivation, supply, possession, production and use of cannabis for medicinal purposes. This mandate forms part of the Government of St. Vincent and the Grenadines’ vision to establish a well-regulated export-oriented medicinal cannabis industry.
Visit MCA.VC.

MIAMI, Aug. 12, 2019 /PRNewswire-HISPANIC PR WIRE/ — Cansortium Inc. (”Cansortium” or the “Company”) (CSE: TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its global retail footprint with the July 25 opening of a new Fluent dispensary in a prime location at the San Patricio Town Center in Calle Tabonuco, Guaynabo, Puerto Rico.

Cansortium’s Chief Executive Officer Jose Hidalgo noted, “The opening of our second Fluent dispensary in Puerto Rico is further evidence that we are executing our growth plan by steadily expanding our dispensary network to enhance access to our premium-quality Fluent cannabis products for medical marijuana patients in key markets. Puerto Rico has more than 92,000 certified medical marijuana patients and offers reciprocity to all medical cannabis card holders from any US state.

“In addition to our two dispensaries in Puerto Rico, we operate 15 Fluent dispensaries in Florida with plans to have 30 in operation or secured by the end of 2019, one Fluent dispensary in Pennsylvania with plans to open two more, and we offer home delivery across the entire state of Texas where we are one of only three licensed medical marijuana providers. We are excited to bring our high-quality consistently-formulated Fluent products to more customers in Puerto Rico and other key markets, and to help consumers in those markets become Fluent in the benefits of cannabis.”

The new 2,200 square-foot dispensary is the Company’s second in Puerto Rico, joining the company’s San Juan dispensary that opened in January 2018. Conveniently located in an upscale mall in San Patricio, one of the most exclusive neighborhoods along the northern coast of Puerto Rico, the location is easily accessed from the PR-2, PR-23 and PR-20 highways. In celebration of its opening, the San Patricio dispensary is offering specials during its first several weeks of operation as it builds up its inventory to represent a complete assortment of Fluent-branded products.

The Fluent brand continually strives to set the standard for premium quality, consistently-formulated cannabis products. Each of the Company’s dispensaries will carry a complete assortment of Fluent premium dried flower, and full spectrum concentrates and cartridges, as well as creams, drops, capsules and suppositories. All Fluent products in the Company’s Puerto Rican dispensaries use high-quality cannabis that is cultivated, processed and packaged in our state-of-the-art Puerto Rican facilities in strict compliance with the country’s medical marijuana regulations. For consumers, the sleek, modern dispensaries provide a warm, welcoming, professional environment, with private consultation rooms and knowledgeable staff who carefully guide patients in selecting the right products and carefully safeguard patient privacy.

For a complete list of Fluent dispensary locations, current promotions and rewards programs and hours of operation, or to explore the entire Fluent product line and place an online order for home delivery, visit https://getfluent.com/.

ABOUT CANSORTIUM INC.
Cansortium is a global medical cannabis company operating in highly populous medical cannabis markets with a mission to deliver the highest standards of cannabis care from nursery to lab to shelf. Headquartered in Miami, FL and operating under the recently-launched Fluent™ brand (formerly Knox Medical), the Company through its subsidiaries operates cultivation, processing and dispensary facilities across Florida, Texas, Puerto Rico and a dispensary license in Pennsylvania. The Company also has licensed cultivation facilities in Colombia and Canada, with licensing pending in Michigan.

Cansortium Inc.’s common shares and warrants trade on the CSE under the symbol “TIUM.U” and “TIUM.WT.U” respectively.

Forward-Looking Information

Certain information in this news release, may constitute forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events.

Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in the public documents of the Company available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

For information on Cansortium Inc., please visit www.cansortium.com.